Cargando…

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules

Background: Fine needle aspiration (FNA) cytology, a diagnostic test central to thyroid nodule management, may yield indeterminate results in up to 30% of cases. The Afirma® Genomic Sequencing Classifier (GSC) was developed and clinically validated to utilize genomic material obtained during the FNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yangyang, Choi, Yoonha, Babiarz, Joshua E., Kloos, Richard T., Kennedy, Giulia C., Huang, Jing, Walsh, P. Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620518/ https://www.ncbi.nlm.nih.gov/pubmed/31333584 http://dx.doi.org/10.3389/fendo.2019.00438

Ejemplares similares

Shear wave elastography and Afirma™ gene expression classifier in thyroid nodules with indeterminate cytology: a comparison study
por: Azizi, Ghobad, et al.
Publicado: (2018)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019)

MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020)

The Diagnostic Performance of Afirma Gene Expression Classifier for the Indeterminate Thyroid Nodules: A Meta-Analysis
por: Liu, Ying, et al.
Publicado: (2019)

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
por: Hu, Mimi I, et al.
Publicado: (2021)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making
por: Kloos, Richard T.
Publicado: (2017)

Prevalence of cancer and the benign call rate of afirma gene classifier in (18)F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
por: Endo, Mayumi, et al.
Publicado: (2021)

Use of the Afirma® Gene Expression Classifier for Preoperative Identification of Benign Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytopathology
por: Ali, Syed Z., et al.
Publicado: (2013)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes
por: Baca, Sylvan C., et al.
Publicado: (2017)

Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis
por: Silaghi, Cristina Alina, et al.
Publicado: (2021)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
por: Zhou, Ling, et al.
Publicado: (2023)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020)

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
por: Capezzone, Marco, et al.
Publicado: (2021)

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study †
por: Kandil, Emad, et al.
Publicado: (2023)

Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples
por: Angell, Trevor E., et al.
Publicado: (2019)

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier
por: Randolph, Gregory W., et al.
Publicado: (2022)

Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer
por: Ali, Syed Z., et al.
Publicado: (2019)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2019)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study
por: Steward, David L., et al.
Publicado: (2018)

Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules
por: Jin, Xiaobing, et al.
Publicado: (2022)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
por: Dharampal, Navjit, et al.
Publicado: (2022)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
por: Censi, Simona, et al.
Publicado: (2017)

Clinical value of FNA puncture feeling in the diagnosis of non-diagnostic and indeterminate thyroid nodules
por: Wu, Jintao, et al.
Publicado: (2022)

A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials
por: Zafereo, Mark, et al.
Publicado: (2020)

Diagnostic performance of ultrasound risk stratification systems on thyroid nodules cytologically classified as indeterminate: a systematic review and meta-analysis
por: Xing, Zhichao, et al.
Publicado: (2023)

Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature
por: Pontieri, Gilda, et al.
Publicado: (2018)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

MON-569 Performance of American Thyroid Association Sonographic Risk and Gene Expression Classifier in the Diagnosis of Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytology
por: Arosemena, Marilyn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cmtn1fv7mct5d3qoqu9brnp7rg